In this week's issue of #JAMADermatology, Jastrzb-Mikiewicz and colleagues take an important early step in examining the impacts of GLP-1RAs on HS comorbidity and mortality
These medications, originally developed for diabetes management, demonstrate significant weight reduction effects through specific biological mechanisms
We are active at the state, federal and international levels of government and regulation
Vibhu Tewary 14:10 Yeah, I can take this one
Dosing, timing, and lifestyle guidance matter, a lot
SGLT2 Inhibitors Examples include: Empagliflozin Dapagliflozin These medicines are particularly important because they can help protect kidney function and reduce the progression of chronic kidney disease in suitable patients